Moreover, it prevents pulmonary arterial hypertension (PAH) by increasing Sirt3 expression, deacetylating cyclophilinD, and preventing mPTP opening in a monocrotaline (MC)-treated rat model [173]. Here, SIRT3 is linked to pulmonary arterial hypertension.